Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer

American Journal of Neuroradiology

Volumn 34, Issue 8, 2013, Pages 1632-1636

  McDermott, M ^a   Hughes, M ^b   Rath, T ^b   Johnson, J T ^b   Heron, D E ^b   Kubicek, G J ^c   Kim, S W ^b   Ferris, R L ^b   Duvvuri, U ^b   Ohr, P J ^b   Branstetter, B F ^b  

^a NEW YORK UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPAMIDOL;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE SURVEILLANCE; ENDOSCOPY; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOPHARYNX; LARYNX; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOUTH CAVITY; NASOPHARYNX; OROPHARYNX; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; RECURRENCE RISK; RECURRENT CANCER; RETROSPECTIVE STUDY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; PENNSYLVANIA; POSITRON-EMISSION TOMOGRAPHY; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SENTINEL SURVEILLANCE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84883106357     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3494     Document Type: Article

References (17)

1. Cancer Facts and Figures 2011. American Cancer Society Web site. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-029771.pdf. Accessed October 28, 2012
2. Agarwal V, Branstetter B, Johnson J. Indications for PET/CT in the head and neck. Otolaryngol Clin North Am 2008;41:23-49
3. Branstetter B, Blodgett T, Zimmer L, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005;235:580-86
4. Andrade RS, Heron DE, Degirmenci B, et al. Post-treatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 2006;65:1315-22
5. Goerres GW, Schmid D, Bandhauer F, et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130:105-09
6. Porceddu SV, Jarmolowski D, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)-radiotherapy in head and neck cancer. Head Neck 2005;27:175-81
7. Zimmer L, Snyderman C, Fukui M, et al. The use of combined PET/CT for localizing recurrent head and neck cancer: the Pittsburgh experience. Ear Nose Throat J 2005;84:104,106,108-110
8. National Comprehensive Cancer Network. http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp#head-And-neck. Accessed October 28, 2012
9. Beswick DM, Gooding WE, Johnson JT, et al. Temporal patterns of head and neck squamous cell carcinoma recurrence with positronemission tomography/computed tomography monitoring. Laryngoscope 2012;122:1512-17
10. Yao M, Graham MM, Smith RB, et al. Value of FDG PET in assessment of treatment response and surveillance in head-And-neck cancer patients after intensity modulated radiation treatment: a preliminary report. Int J Radiat Oncol Biol Phys 2004;60:1410-18
11. Ong SC, Schoder H, Lee NY, et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med 2008;49:532-40
12. Nayak JV, Walvekar RR, Andrade RS, et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope 2007;117:2129-34
13. Kubota K, Yokoyama J, Yamaguchi K, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radiochemotherapy comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004:31:590-95
14. Ryan WR, Fee WE, Le QT, et al. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 2005;115:645-50
15. Brkovich V, Miller F, Karnad A, et al. The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 2006;116:855-58
16. Greven K, Williams D, McGuirt W, et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 2001;23:942-46
17. Rodrigues RS, Bozza FA, Christian PE, et al. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast- enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. J Nucl Med 2009;50:1205-13